Business Standard

Monday, December 23, 2024 | 03:46 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Beryl Drugs standalone net profit declines 74.07% in the September 2018 quarter

Image

Capital Market

Sales rise 9.01% to Rs 3.51 crore

Net profit of Beryl Drugs declined 74.07% to Rs 0.14 crore in the quarter ended September 2018 as against Rs 0.54 crore during the previous quarter ended September 2017. Sales rose 9.01% to Rs 3.51 crore in the quarter ended September 2018 as against Rs 3.22 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales3.513.22 9 OPM %9.977.45 -PBDT0.290.21 38 PBT0.250.11 127 NP0.140.54 -74

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 15 2018 | 10:48 AM IST

Explore News